Bioequivalence is the property wherein two drugs with identical active ingredients or two different dosage forms of the same drug possess similar bioavailability and produce the same effect at the site of physiological activity. Bioequivalence is determined by pharmacokinetic studies to determine whether a commercially available brand product and a potential to market generic version share core attributes. Determining the absolute bioavailability of a drug is done through a pharmacokinetic study.
Cardiovascular Pharmacology is a part of pharmacology that arrangements with the drug’s use to cardiovascular diseases. Several classes of cardiovascular agents are accessible to treat the different cardiovascular conditions. It essentially contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development. Medicines that are utilized to the cardiovascular disorders are Anti-coagulants, Beta blockers, calcium channel blockers, Diuretics, Vasodilators.
Abstracts enquiry
Finance enquiry
Contact Enquiry
Sponsors / Advertising
Meetings International Pte Ltd, 28 Maxwell Road, 03-05 Red Dot Traffic, Singapore, 069120.